Sales rise 126.57% to Rs 267.65 crore
Sales rise 122.00% to Rs 594.14 crore
Sales rise 10.71% to Rs 0.62 crore
Total Operating Income rise 5.94% to Rs 7859.89 crore
Sales rise 88.74% to Rs 38.90 crore
Sales rise 11.90% to Rs 103.80 crore
Sales rise 10.16% to Rs 32.74 crore
Sales rise 36.06% to Rs 1463.63 crore
Glenmark Pharmaceuticals today received the India Pharma Innovation of the Year Award and was adjudged runners-up in the India Pharma CSR of the Year category as part of the India Pharma India Medical Device Awards 2022 The seventh edition of the annual awards was jointly organized by the Department of Pharmaceuticals Ministry of Chemicals Fertilizers The Federation of Indian Chambers of Commerce Industry FICCI and […]
The Board of Jammu and Kashmir Bank at its meeting held on 27 April 2022 has appointed Rajni Saraf as the Chief Financial Officer of the Bank with effect from 27 April 2022 till engagement of new CFO in place of Balvir Singh Gandhi who ceased to be Chief Financial Officer of the Bank
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Reg. No. INM000010940, SEBI RA Regn. No: INH000000248, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
